Instil Bio (TIL) Net Income (2020 - 2026)
Instil Bio (TIL) posted quarterly Net Income of -$7.9 million for Q1 2026, up 74.14% year-over-year from -$4.5 million in Q1 2025, and up 24.03% quarter-over-quarter from -$10.4 million in Q4 2025.
Instil Bio (TIL) Net Income (2020 - 2026) Analysis & Trends
Instil Bio's Net Income history runs 7 years deep, the most recent figure standing at -$7.9 million for Q1 2026.
- In Q1 2026, Net Income rose 74.14% year-over-year to -$7.9 million; the TTM figure through Mar 2026 stood at -$58.0 million (up 29.46% YoY), while the FY2025 annual figure was -$80.6 million, up 61.26% from the prior year.
- Net Income for Q1 2026 stood at -$7.9 million, up from -$10.4 million in the prior quarter.
- The five-year high for Net Income was -$7.9 million in Q1 2026, with the low at -$67.4 million in Q3 2023.
- The 5-year median for Net Income is -$24.0 million (2025), against an average of -$32.0 million.
- The sharpest annual moves came in 2022 and 2023: Net Income tumbled 133.99% in 2022, then jumped 76.0% in 2023.
- Instil Bio's Net Income stood at -$53.8 million in 2022, then surged by 76.0% to -$12.9 million in 2023, then dropped by 4.22% to -$13.5 million in 2024, then increased by 22.96% to -$10.4 million in 2025, then gained by 24.03% to -$7.9 million in 2026.
- Business Quant data shows TIL's Net Income at -$7.9 million in Q1 2026, -$10.4 million in Q4 2025, and -$15.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn | 164.49 Mn |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn | -13.27 Mn |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn | -355.03 Mn |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - | 81.49 Mn |
| 10 | Instil Bio | 50.56 Mn | 50.56 Mn | - | -6.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.60 Mn |
| Mar 31, 2026 | -7.88 Mn |
| Dec 31, 2025 | -10.38 Mn |
| Sep 30, 2025 | -15.71 Mn |
| Jun 30, 2025 | -23.98 Mn |
| Mar 31, 2025 | -30.49 Mn |
| Dec 31, 2024 | -13.47 Mn |
| Sep 30, 2024 | -23.98 Mn |
| Jun 30, 2024 | -14.22 Mn |
| Mar 31, 2024 | -23.87 Mn |
| Dec 31, 2023 | -12.93 Mn |
| Sep 30, 2023 | -67.43 Mn |
| Jun 30, 2023 | -18.66 Mn |
| Mar 31, 2023 | -57.07 Mn |
| Dec 31, 2022 | -53.84 Mn |
| Sep 30, 2022 | -56.22 Mn |
| Jun 30, 2022 | -58.99 Mn |
| Mar 31, 2022 | -54.12 Mn |
| Dec 31, 2021 | -55.35 Mn |
| Sep 30, 2021 | -43.01 Mn |